These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 31802204)

  • 1. Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder.
    Fırat E; Aybek Z; Akgün Ş; Küçüker K; Akça H; Aybek H
    World J Urol; 2020 Oct; 38(10):2571-2575. PubMed ID: 31802204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADRB3, ROCK2, and GEF Levels in Overactive Bladder Patients.
    Fırat E; Aybek Z; Aybek H
    Int Neurourol J; 2022 Feb; 26(Suppl 1):S8-14. PubMed ID: 35236048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Letter to the Editor regarding the article "Relation of ADRB3, GEF, ROCK2 gene polymorphisms to clinical findings in overactive bladder".
    Gao L; Deng C
    World J Urol; 2022 Mar; 40(3):879. PubMed ID: 33439276
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of β-3 adrenergic receptor polymorphism in overactive bladder.
    Meekins AR; Murphy SK; Grenier C; Huang Z; Bradley MS; Amundsen CL; Wu J; Siddiqui NY
    Neurourol Urodyn; 2019 Jun; 38(5):1261-1265. PubMed ID: 31009102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between the Trp64Arg polymorphism of the ADRB3 gene and overactive bladder.
    Çırakoğlu A; Fejzullahu A; Benli E; Yuce A; Ayyıldız A; Aynacıoğlu AŞ
    Neurourol Urodyn; 2021 Sep; 40(7):1780-1785. PubMed ID: 34260097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Gene Polymorphisms on the Success of Anticholinergic Treatment in Children with Overactive Bladder.
    Gurocak S; Konac E; Ure I; Senol C; Onen IH; Sozen S; Menevse A
    Dis Markers; 2015; 2015():732686. PubMed ID: 26166934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis.
    Qu HC; Zhang W; Liu YL; Wang P
    Genet Mol Res; 2015 Mar; 14(1):2495-501. PubMed ID: 25867395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between polymorphism of beta3-adrenoceptor gene and overactive bladder.
    Honda K; Yamaguchi O; Nomiya M; Shishido K; Ishibashi K; Takahashi N; Aikawa K
    Neurourol Urodyn; 2014 Apr; 33(4):400-2. PubMed ID: 24038238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the Trp 64 Arg polymorphism of the beta 3-adrenoceptor gene and idiopathic overactive bladder.
    Ferreira CE; Fonseca AM; Silva ID; Girão MJ; Sartori MG; Castro RA
    Am J Obstet Gynecol; 2011 Jul; 205(1):82.e10-4. PubMed ID: 21529759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms.
    Yamamichi F; Shigemura K; Behnsawy HM; Yamashita M; Shirakawa T; Fujisawa M
    Int J Clin Exp Pathol; 2015; 8(9):11863-70. PubMed ID: 26617941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
    Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
    Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Polymorphism in the
    Ciećwież SM; Lewandowska K; Boroń A; Brodowski J; Kociszewski J; Clark JS; Ciechanowicz A
    J Clin Med; 2022 Dec; 11(24):. PubMed ID: 36556105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting self-perceived antimuscarinic therapy effectiveness on overactive bladder symptoms using the Overactive Bladder 8-Question Awareness Tool.
    Villacampa F; Ruiz MA; Errando C; Arlandis S; Arumí D; Lizarraga I; Rejas J
    Int Urogynecol J; 2013 Apr; 24(4):573-81. PubMed ID: 23111865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring biomarkers in the overactive bladder: Alterations in miRNA levels of a panel of genes in patients with OAB.
    Fırat E; Aybek Z; Akgün Ş; Küçüker K; Akça H; Aybek H
    Neurourol Urodyn; 2019 Aug; 38(6):1571-1578. PubMed ID: 31157926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Arabic linguistic version of the 8-item overactive bladder questionnaire (OAB-V8).
    Al-Shaiji TF; Alkabbani M; El-Nahas AR; Thahir A; Almutairi MF; Al-Terki A
    Int Urogynecol J; 2019 Dec; 30(12):2153-2156. PubMed ID: 30788523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the 8-item overactive bladder questionnaire (OAB-v8) using item response theory.
    Peterson AC; Sehgal A; Crump RT; Baverstock R; Sutherland JM; Carlson K
    Neurourol Urodyn; 2018 Mar; 37(3):1095-1100. PubMed ID: 28976596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we use the shorter Thai-version quality of life and symptoms questionnaires in women with overactive bladder?
    Bunyavejchevin S; Liao L; Lu SH; Choo MS; Rabbani KJ; Havanond P
    J Obstet Gynaecol Res; 2015 Aug; 41(8):1260-5. PubMed ID: 26081949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta3-adrenoceptors in urinary bladder.
    Yamaguchi O; Chapple CR
    Neurourol Urodyn; 2007; 26(6):752-6. PubMed ID: 17600372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of the Chinese Overactive Bladder Symptom Score for assessing overactive bladder syndrome in a RESORT study.
    Hung MJ; Chou CL; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
    J Formos Med Assoc; 2013 May; 112(5):276-82. PubMed ID: 23660224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multiplexed analysis approach identifies new association of inflammatory proteins in patients with overactive bladder.
    Ma E; Vetter J; Bliss L; Lai HH; Mysorekar IU; Jain S
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F28-34. PubMed ID: 27029431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.